Chain Bridge I
Status: Live Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $230.00M |
|---|---|
| IPO Date | Nov 10, 2021 |
| CEO | Andrew Cohen |
| Left Lead | Cowen |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 18 + 9 + 9 |
| IPO Sector |
Technology
Companies possessing emerging, innovative technology that can help the U.S. government and its allies successfully compete in the national security arena |
| IPO Geography | US/Canada |
| Target Company | Phytanix Bio |
| Deal Announced | Jul 22, 2024 |
| Deal Size, $M | $58.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Nov 14, 2024 |
CBRG
CBRGU
CBRGW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Chain Bridge I:
- Structure and cap table
- 6 directors & officers
- 37 filings and events
- 2 underwriters
- 2 deal advisors
- 1 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Andrew Cohen | 46 | CEO and Director |
| Andrew Kucharchuk | 43 | CFO |
| Daniel Wainstein | 44 | Chairman and Director |
| Lewis Silberman | 44 | Director |
| Paul Baron | 53 | Director |
| Oliver Wiener | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Cowen | Joint BR | 14,000,000 | units |
| Wells Fargo | Joint BR | 6,000,000 | |
| 20,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| BCMA | 3.50 | % |
Sign in to view more advisor data.